ChatGPTs Stock Portfolio Takes A Major Hit

Welcome back to our ongoing experiment testing if an AI can beat the market. For the past fourteen weeks, we've been tracking a micro-cap stock portfolio managed entirely by ChatGPT. The journey has had its ups and downs, but this week delivered a harsh dose of reality, highlighting the inherent risks of investing in speculative assets.

The Experiment's Premise

The goal is simple: to determine if ChatGPT, given a set of criteria for analyzing micro-cap stocks, can generate returns that outperform standard market indices over a six-month period. Each week, we follow the AI's decisions, tracking its performance and analyzing its strategy. Up until now, the portfolio has shown moments of promise, navigating the volatile micro-cap space with mixed results.

A Biotech Bet Goes South

This week's primary drama centered around a significant holding in the portfolio, FBIO. The company's value was heavily tied to the outcome of a key clinical trial. Unfortunately for the AI's portfolio, news broke that the trial was denied, sending the company's stock price into a freefall. This single event erased weeks of gains and served as a stark reminder of the binary outcomes often seen in the biotech sector. When a promising drug or treatment fails to gain approval, investor confidence evaporates almost instantly, and the stock price reflects that devastation.

Analyzing the Damage

The impact on the portfolio was immediate and severe. FBIO's stock plummeted by over 70% in a single day, causing a double-digit percentage loss for the entire AI-managed fund for the week. This sharp decline puts the portfolio significantly behind its benchmarks, such as the Russell 2000 index, which tracks small-cap stocks. It's a classic example of how a lack of diversification and a high-risk position can quickly lead to substantial losses.

What Will the AI Do Next?

The most pressing question now is how ChatGPT will react to this adverse event. Will it cut its losses and sell the remainder of the FBIO position? Or will it interpret the low price as a buying opportunity, a classic but risky value investing play? The AI's next move will provide crucial insight into its risk management protocols and long-term strategy. This event serves as a critical test for the AI: can it handle a major loss logically, or will its algorithm be unable to adapt to such a sudden and drastic change in a stock's fundamentals? For a more detailed breakdown of the weekly numbers, you can often find additional analysis on the author's personal blog.

This setback marks a pivotal moment in the experiment. While the losses are significant, the lessons learned about AI-driven investment strategies in high-risk sectors are invaluable. Join us next week to see how the portfolio attempts to recover.